Fatal Familial Insomnia (FFI) is a genetic prion disease caused by a point mutation in the prion protein gene (PRNP) characterized by prominent thalamic atrophy, diffuse astrogliosis and moderate deposition of PrP Sc in the brain. Here, for the first time, we demonstrate that the olfactory mucosa (OM) of patients with FFI contains trace amount of PrP Sc detectable by PMCA and RT-QuIC. Quantitative PMCA analysis estimated a PrP Sc concentration of about 1 Ã 10-14g/ml. In contrast, PrP Sc was not detected in OM samples from healthy controls and patients affected by other neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease and frontotemporal dementia. These results indicate that the detection limit of these assays is in the order of a single PrP Sc oligomer/molecule with a specificity of 100%.
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia / Redaelli, Veronica; Bistaffa, Edoardo; Zanusso, Gianluigi; Salzano, Giulia; Sacchetto, Luca; Rossi, Martina; De Luca, Chiara Maria Giulia; Di Bari, Michele; Portaleone, Sara Maria; Agrimi, Umberto; Legname, Giuseppe; Roiter, Ignazio; Forloni, Gianluigi; Tagliavini, Fabrizio; Moda, Fabio. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 7:(2017), pp. 1-8. [10.1038/srep46269]
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia
Bistaffa, Edoardo;Zanusso, Gianluigi;Salzano, Giulia;Rossi, Martina;Legname, GiuseppeMembro del Collaboration group
;Forloni, Gianluigi;Moda, Fabio
2017-01-01
Abstract
Fatal Familial Insomnia (FFI) is a genetic prion disease caused by a point mutation in the prion protein gene (PRNP) characterized by prominent thalamic atrophy, diffuse astrogliosis and moderate deposition of PrP Sc in the brain. Here, for the first time, we demonstrate that the olfactory mucosa (OM) of patients with FFI contains trace amount of PrP Sc detectable by PMCA and RT-QuIC. Quantitative PMCA analysis estimated a PrP Sc concentration of about 1 Ã 10-14g/ml. In contrast, PrP Sc was not detected in OM samples from healthy controls and patients affected by other neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease and frontotemporal dementia. These results indicate that the detection limit of these assays is in the order of a single PrP Sc oligomer/molecule with a specificity of 100%.File | Dimensione | Formato | |
---|---|---|---|
srep46269.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
768.64 kB
Formato
Adobe PDF
|
768.64 kB | Adobe PDF | Visualizza/Apri |
srep46269-s1.pdf
accesso aperto
Descrizione: Supplementary information
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
431.34 kB
Formato
Adobe PDF
|
431.34 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.